Oncosec medical inc (ONCS)
Income statement / Quarterly
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Apr'11
Revenue

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

Expenses:
Research and development

6,055

5,420

-

-

4,746

4,739

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

-

-

-

4,222

-

-

6,854

4,153

2,994

3,413

3,314

2,656

2,882

3,099

3,592

3,376

4,113

3,659

3,839

3,932

2,859

2,501

1,862

1,700

1,458

773

656

707

614

1,180

643

701

508

515

216

General and administrative

7,468

4,418

2,782

2,691

3,733

2,764

5,746

5,138

5,290

2,514

2,557

2,015

2,547

2,548

2,969

2,874

2,924

3,375

2,736

2,053

1,758

1,558

1,680

2,115

1,142

1,214

1,104

1,001

983

816

920

887

671

678

279

Loss from operations

-13,523

-9,838

-7,519

-6,913

-8,479

-7,503

-12,600

-9,292

-8,285

-5,927

-5,872

-4,671

-5,429

-5,648

-

-

-

-

-

-5,986

-4,618

-

-3,543

-3,816

-2,601

-1,988

-1,760

-1,709

-1,597

-1,997

-1,563

-1,588

-1,180

-1,194

-496

Other income, net

46

82

106

113

105

114

240

91

15

26

-25

110

42

46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments to fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,613

-1,397

3,977

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

761

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

8

12

12

19

24

27

29

74

93

69

-

Interest expense

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-859

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant inducement expense

-

-

-

-

-

-

-

-

2,465

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency exchange (loss) gain, net

-154

-3

-95

-77

63

-171

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency exchange loss, net

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realized loss on sale of securities, net

-

-

0

0

0

-12

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-13,631

-9,760

-7,511

-6,879

-8,310

-7,573

-12,439

-10,060

-10,735

-5,900

-5,897

-4,560

-5,387

-5,602

-6,561

-6,251

-7,037

-7,035

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,618

-4,060

-3,543

-3,816

-2,610

-2,000

-1,772

-1,728

-1,621

-2,024

-1,593

-811

-2,671

2,714

-497

Provision for income taxes

2

-

-9

3

4

2

-0

0

0

0

0

0

0

1

0

0

0

2

0

1

0

0

0

0

-9

50

0

0

0

2

0

0

0

2

1

Net loss

-13,634

-9,760

-7,502

-6,883

-8,315

-7,575

-12,439

-10,060

-10,736

-5,900

-5,897

-4,560

-5,387

-5,603

-6,561

-6,251

-7,037

-7,037

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per common share

-1.27

-0.92

-0.56

-1.03

-1.33

-1.37

-7.20

-1.98

-0.31

-0.26

-0.28

-0.22

-0.27

-0.29

-0.37

-0.37

-0.42

-0.47

-

-

-

-0.33

-

-

-

-0.01

-

-

-

-0.02

-

-

-

-

-

Weighted average shares used in computing basic and diluted net loss per common share

10,712

10,648

9,756

6,664

6,272

5,519

-46,150

5,087

34,794

22,318

21,300

20,704

19,733

19,020

17,499

16,971

16,761

14,826

-

-

-

12,231

-

-

-

144,247

-

-

-

87,892

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,987

-4,618

-4,061

-3,543

-3,816

-2,600

-2,051

-1,772

-1,728

-1,621

-2,026

-1,593

-811

-2,671

2,712

-499

Basic net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.48

-0.38

-

-

-0.37

-0.01

-

-

-0.01

-0.02

-

-

-0.01

-0.05

0.05

-0.01

Diluted net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.48

-0.38

-

-

-0.37

-0.01

-

-

-0.01

-0.02

-

-

-0.01

-0.05

0.05

-0.01

Weighted average shares used in computing basic net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,349

12,312

-

-

10,364

176,838

-

-

117,859

102,895

-

-

68,222

56,856

56,856

61,611

Weighted average shares used in computing diluted net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,349

12,312

-

-

10,364

176,838

-

-

117,859

102,895

-

-

68,222

56,856

56,905

61,611